Clinical Trial Update: Randomized Study of Albuterol in Patients With Facioscapulohumeral Muscular Dystrophy [NA]

View source ↗

Summary

A randomized study of albuterol in patients with facioscapulohumeral muscular dystrophy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Facioscapulohumeral Muscular Dystrophy

Drugs mentioned

• Albuterol (albuterol)

Snippet

Sponsor: Ohio State University | Conditions: Muscular Dystrophy, Facioscapulohumeral | NA | Status: COMPLETED